• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPfizer

Pfizer

Page 37 of 38
Facebook earnings and MSG split — 5 things to know today
Features
Facebook earnings and MSG split — 5 things to know today
By Ben GeierOctober 28, 2014
New Targets and new houses (oh, and Ebola) — 5 things to know today
Features
New Targets and new houses (oh, and Ebola) — 5 things to know today
By Ben GeierOctober 24, 2014
Are U.S. corporate tax inversions a necessary crisis?
Finance
Are U.S. corporate tax inversions a necessary crisis?
By Robert LitanJuly 18, 2014
Canada: A penalty box for pharma innovation
Canada: A penalty box for pharma innovation
By David J. KapposJuly 2, 2014
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Finance
AstraZeneca fails to win FDA panel backing for cancer treatment
By John KellJune 26, 2014
AstraZeneca shareholders upset by “quick” Pfizer rejection
Finance
AstraZeneca shareholders upset by “quick” Pfizer rejection
By Laura LorenzettiMay 20, 2014
AstraZeneca rejects higher ‘final’ offer from Pfizer
Finance
AstraZeneca rejects higher ‘final’ offer from Pfizer
By Laura LorenzettiMay 19, 2014
Does the AstraZeneca-Pfizer deal make scientific sense?
Features
Does the AstraZeneca-Pfizer deal make scientific sense?
By Jennifer ReingoldMay 15, 2014
Pfizer admits to potential job losses in AstraZeneca takeover
Finance
Pfizer admits to potential job losses in AstraZeneca takeover
By Laura LorenzettiMay 13, 2014
Pfizer prepares to woo U.K. lawmakers in bid for rival AstraZeneca
Finance
Pfizer prepares to woo U.K. lawmakers in bid for rival AstraZeneca
By Laura LorenzettiMay 12, 2014
AstraZeneca shares climb in hopes of bigger Pfizer offer
Finance
AstraZeneca shares climb in hopes of bigger Pfizer offer
By Laura LorenzettiMay 9, 2014
Pfizer’s massive tax play for AstraZeneca
Finance
Pfizer’s massive tax play for AstraZeneca
By Cyrus SanatiApril 29, 2014
Behind Pfizer’s latest upheaval at the top
Features
Behind Pfizer’s latest upheaval at the top
By Patricia SellersDecember 17, 2013
Inside Pfizer’s palace coup
Inside Pfizer’s palace coup
By Peter Elkind and Jennifer ReingoldJuly 28, 2011
Pfizer wins big Celebrex ruling
Finance
Pfizer wins big Celebrex ruling
By Roger ParloffNovember 20, 2007
1...
  • 34
  • 35
  • 36
  • 37
  • 38
38
Most Popular
Economy
How Scott Bessent used financial engineering to finance the $2 trillion deficit while leaving it untouched—and created a $1.45 trillion shortfallplaceholder alt text
By Eva RoytburgAugust 8, 2026
Middle East
The emerging deal to reopen the Strait of Hormuz reportedly recognizes Iran’s control—and the U.S. may have to accept itplaceholder alt text
By Jason MaAugust 7, 2026
Real Estate
The tables have turned: Florida and Texas are the biggest losers in the housing market as Ohio emerges a surprise winnerplaceholder alt text
By Sydney LakeAugust 8, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.